CSRHub social responsibility and sustainability information on BioMarin Pharmaceutical Inc..

BioMarin Pharmaceutical Inc.

Subscribe to see all available data

BioMarin is a multinational biopharmaceutical company that specializes in providing first-to-market therapeutics to patients with rare genetic diseases. The company's product portfolio comprises three approved products and multiple clinical and preclinical product candidates. Approved products include Naglazyme for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan Tablets, a product for the treatment of phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. The company was established in 1997 and employs a staff of 675 worldwide.

Ticker: BMRN ISIN: US09061G1013
Address: 105 Digital Drive, USA, Novato, CA, 94949 Website:
Phone #: 415-5066700 CSR Web Area: SUBSCRIPTION INFO

CSR/Sustainability Ratings for BioMarin Pharmaceutical Inc.

  Overall Community Employees Environment Governance
BioMarin Pharmaceutical Inc. 44 50 46 41 41
Biotechnology
SUBSCRIPTION INFO
All company average 56 58 61 60 53
USA
SUBSCRIPTION INFO
Special Issues:

Percentile Corporate Social Responsibility Rankings (show)

CSR Performance History for BioMarin Pharmaceutical Inc.

There is no history for the selected element(s).

Only subscribers can interact with the graph.

* — this element is not available.

More CSR Rating Details

  Community Employees
Community Dev & Philanthropy Product Human Rights & Supply Chain Compensation & Benefits Diversity & Labor Rights Training, Health & Safety
BioMarin Pharmaceutical Inc.
SUBSCRIPTION INFO
Biotechnology
SUBSCRIPTION INFO
All company average 57 58 58 60 60 59
USA
SUBSCRIPTION INFO

Environment Governance
Energy & Climate Change Environmant Policy & Reporting Resource Management Board Leadership Ethics Transparency & Reporting
BioMarin Pharmaceutical Inc.
SUBSCRIPTION INFO
Biotechnology
SUBSCRIPTION INFO
All company average 57 61 59 49 54 51
USA
SUBSCRIPTION INFO

More Percentile Ranking ESG Details (show)

0 Special Issues That Affect BioMarin Pharmaceutical Inc. (see a list of issues here)

# of Sources
Biotechnology
SUBSCRIPTION INFO
Overall database
USA
SUBSCRIPTION INFO

CSRHub Has 18 Data Sources (14 Are Currently Active) for BioMarin Pharmaceutical Inc.

= sources impacting the current ratings
= sources not impacting the current ratings, but included in earlier ratings for this company
SUBSCRIPTION INFO
SUBSCRIPTION INFO
SUBSCRIPTION INFO
SUBSCRIPTION INFO
SUBSCRIPTION INFO
SUBSCRIPTION INFO
SUBSCRIPTION INFO
SUBSCRIPTION INFO
SUBSCRIPTION INFO
SUBSCRIPTION INFO
SUBSCRIPTION INFO
SUBSCRIPTION INFO
SUBSCRIPTION INFO
SUBSCRIPTION INFO
SUBSCRIPTION INFO

Original sustainability and CSR data values (show)

Flags for BioMarin Pharmaceutical Inc.

(Other Indicators - things that don’t affect ratings but that help identify or classify companies)

SUBSCRIPTION INFO
SUBSCRIPTION INFO
SUBSCRIPTION INFO
SUBSCRIPTION INFO

Name Variants for BioMarin Pharmaceutical Inc.

You have put report(s) in your cart
Go to my cart
Ok